Cardillo et al. [30] provided solid evidence that SG is more efficient in homologous recombination repair (HRR)-proficient cancer cells with a high Trop-2 expression as well as in the HRR-deficient cancers with low to moderate Trop-2 protein expression [30]. This evidence concerns the gene TACSTD2 and cancer.